Rebamipide

CAS 90098-04-7 1 current record 2 historicalSmall Molecule

Who holds supplier records for Rebamipide? 1 organisation holds a current record for Rebamipide: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Rebamipide: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/rebamipide

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rebamipide. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Maithri Laboratories Private Limited
    Active DMF 43855 · latest filing Mar 2026
    India Company GMP cert on record
Need Rebamipide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Rebamipide are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Jiangxi Synergy Pharmaceutical Co., Ltd
    China · Inactive DMF 21700 · filed Jun 2008
  • Japan · Inactive DMF 15001 · filed Aug 2000

Overview

Rebamipide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1697771).

Chemical identity

IUPAC name
2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
Canonical SMILES
C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
InChIKey
ALLWOAVDORUJLA-UHFFFAOYSA-N
Synonyms
Mucosta, NSC-758955, OPC-12759, Proamipide, Rebamipida, Rebamipide, Rebator, Rebamipidum, OPC 12759, RefChem:878997, A02BX14, Pramipide

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rebamipide?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Rebamipide: Maithri Laboratories Private Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rebamipide Drug Master Files are active?

Maithri Laboratories Private Limited (DMF 43855). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Rebamipide records mean?

2 organisations have only inactive Type II DMFs for Rebamipide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Rebamipide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rebamipide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.